Gillian Smith

+44 (0)1382 383252
Senior Lecturer

Bio

Teaching

Dr Smith is lead for cancer-themed teaching in the School of Medicine. She is Module Manager for final year (Level 4) undergraduate Biological and Biomedical Sciences modules in Cancer Biology (BS42007) and Cancer Pharmacology and Treatment (BS42027), and module lead and member of the postgraduate MRes Cancer Biology programme team. Together with clinical colleagues Dr Michelle Ferguson and Dr Jonathan Berg, she also leads the BMSc Genetics, Cancer and Personalised Medicine programme for intercalating medical students. She additionally regularly supervises Year 1 MBChB SSC students and is an experienced supervsor of both laboratory-based, data analysis and science communication projects for undergraduate and postgraduate science and medical students. 

Biography

Dr Smith graduated from the University of Edinburgh with a BSc (Hons) degree in Chemistry and PhD in Medicine. Following a short Post-Doctoral Fellow position in the Department of Pathology, University of Edinburgh, she joined the newly created Biomedical Research Institute in the University of Dundee School of Medicine. Following an MRC-funded Post-Doctoral Fellowship in Dundee, she was invited to join the Department of Clinical Pharmacology, Uppsala University Hospital in Sweden as a visiting scientist, before returning to Dundee as Senior Scientist then Senior Lecturer. She is currently based in the Division of Cellular Medicine, where she is teaching lead for cancer-themed teaching and leads a translational research team working with clinical colleagues on novel approaches to personalise treatment and combat drug resistance in ovarian cancer.

Research interests

Translational studies on stratified medicine and drug resistance in ovarian and colorectal cancer. Biomarker discovery and collaborative "bench to bedside" cancer research.

Research

Dr Smith leads a translational research team, working collaboratively with clinical colleagues in oncology, surgery and pathology. We are particularly interested in understanding the molecular basis of drug resistance in common cancers, with current research focussing on ovarian and colorectal cancers, where the development of drug resistant disease frequently limits treatment response. We have created novel drug resistant cell line models which mimic typical clinical treatments, and have used these to identify key resistance modifiers including FGF and AKT-regulated signalling cascades which can be targeted in novel combination chemotherapy approaches. Our laboratory studies are complemented by longitudinal studies in drug sensitive and drug resistant cancer patients which focus both on target and biomarker discovery. Our research programme is currently supported by Medical Research Scotland, the Chief Scientist Office and local charities and we are fortunate to collaborate and share resources within the UK and with international colleagues.

Publications

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
10/2018, Oncotarget
Research Output: Contribution To Journal > Article

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk : A case-control study in unselected white European populations
5/2017, PLoS ONE
Research Output: Contribution To Journal > Article

ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
6/2016, British Journal of Cancer
Research Output: Contribution To Journal > Article

Recurrent Coding Sequence Variation Explains only A Small Fraction of the Genetic Architecture of Colorectal Cancer
5/2015, Scientific Reports
Research Output: Contribution To Journal > Article

MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and-independent mechanisms
4/2015, British Journal of Cancer
Research Output: Contribution To Journal > Article

Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
7/2014, British Journal of Cancer
Research Output: Contribution To Journal > Article

Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet (PUVA) sensitivity
/2013, PLoS ONE
Research Output: Contribution To Journal > Article

Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer
10/2012, British Journal of Cancer
Research Output: Contribution To Journal > Article

Characterization of a Human Keratinocyte HaCaT Cell Line Model to Study the Regulation of CYP2S1
2/2012, Drug Metabolism and Disposition
Research Output: Contribution To Journal > Article

Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy
2/2012, British Journal of Dermatology
Research Output: Contribution To Journal > Article

View full profile on research portal

Press

Gene helps predict which ovarian cancer sufferers will benefit most from chemotherapy

Gillian Smith, Michael Ng, Simon Herrington, Michelle Ferguson & Roland Wolf

19/09/12

1 item of media coverage

Press/Media: Research



View full profile on research portal

Activities

School of Medicine Open Day

Colin Henderson (Participant), Frances Fuller-Pace (Participant), Gillian Smith (Participant), Francisco Inesta-Vaquera (Participant), Susan Bray (Participant), Norman Pratt (Participant), Rosamund Langston (Participant), Suzanne Duce (Participant), Hugh Nicholson (Participant)
8 Sep 2018

Activity: Participating in or organising an event typesFestival/Exhibition

Activity Type: Attendance

Work Experience week

Colin Henderson (Member), Alison McNeilly (Member), Bethany Coull (Member), Gillian Smith (Member), Hugh Nicholson (Member)
30 Jul 2018

Activity: Other activity typesSchools engagement

Activity Type: Other Activity

14th North American ISSX Meeting

Gillian Smith (Participant)
22 Oct 200626 Oct 2006

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

Newcastle Pathology 2005: 3rd Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain and Ireland

Gillian Smith (Participant)
5 Jul 20058 Jul 2005

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

British Society for Investigative Dermatology Annual Meeting

Gillian Smith (Participant)
7 Apr 20039 Apr 2003

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

184th Meeting of the Pathological Society of Great Britain and Ireland

Gillian Smith (Participant)
2 Jul 20025 Jul 2002

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

51st Annual Meeting of the American Society of Human Genetics

Gillian Smith (Participant)
12 Oct 200116 Oct 2001

Activity: Participating in or organising an event typesParticipation in conference

Activity Type: Attendance

View full profile on research portal